Administrative Core

行政核心

基本信息

  • 批准号:
    10588234
  • 负责人:
  • 金额:
    $ 41.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-03-26 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

Abstract The broad objectives of the Administrative Core (Core A) of the Gonorrhea Vaccine (GV)-CRC are to provide the infrastructure needed to help the Center meet its long-term goal of increased understanding and improved control measures for chlamydia and gonorrhea infections. Dr. Ann Jerse will be the Core Leader and a Core Manager will assist her in the running of the core. The activities of Core A are organized around the following five specific aims and a management plan has been developed to address each aim. Aim 1 is to foster interactive and synergistic interactions between Center PIs, co-PIs and Core Leaders to maximize research accomplishments and increase the types of significant breakthroughs that occur when experts in different fields work together. Mechanisms to accomplish this goal include monthly teleconferences for Center investigators and annual GV-CRC meetings where Center PIs, coPIs and Core Leaders present their progress. An outside scientific advisory board (SAB) composed of researchers with diverse experience in STIs will attend one of the GV-CRC meetings and provide critiques on the progress of individual Research Projects, the Research Cores, and the overall Center. Aim 2 is to provide funds, mentorship, and networking opportunities to talented new investigators working in STI research through the Developmental Research Project (DRP) program. Core A will solicit calls for applications and organize the review panel and review process by which awardee will be selected. Core A will also play a role in developing a training plan for the awardee and will provide the DRP awardee with the opportunty to attend and present at an annual NIAID programmatic STI CRC meeting. Aim 3 is to actively facilitate good communications between the Henry Jackson Foundation, who will administer the awards and subawards of the Center, and administrative personnel at the different institutions within the Center. In this way, the accounting responsibilities of the center can be better discharged in an efficient and straightforward manner. Core A will provide administrative oversight with respect to maintaining all assurances for animal and human use. Aim 4 is to regularly communicate with NIH/NIAID program staff so that our progress is transparent and we are aware of changes in programmatic focus. To promote these interactions, NIAID program staff will be invited to the annual internal GV-CRC meetings. Aim 5 is to broaden networks within the STI research community by actively seeking and identifying potential collaborations between Center researchers and investigators at other Centers. Besides helping to identify such collaborations, Core A will consult with NIAID program staff for information on expertises or technologies held by other Centers that might help PIs within our center.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ann E. Jerse其他文献

Gonococcal PorB: a multifaceted modulator of host immune responses
淋球菌孔蛋白B:宿主免疫反应的多面调节因子
  • DOI:
    10.1016/j.tim.2023.10.002
  • 发表时间:
    2024-04-01
  • 期刊:
  • 影响因子:
    14.900
  • 作者:
    Rebekah A. Jones;Ann E. Jerse;Christoph M. Tang
  • 通讯作者:
    Christoph M. Tang
emNeisseria gonorrhoeae/em Coinfection during emChlamydia muridarum/em Genital Latency Does Not Modulate Murine Vaginal Bacterial Shedding
淋病奈瑟菌/鼠衣原体生殖器潜伏期间的合并感染不会调节小鼠阴道细菌脱落
  • DOI:
    10.1128/spectrum.04500-22
  • 发表时间:
    2023-05-18
  • 期刊:
  • 影响因子:
    3.800
  • 作者:
    Delia Onorini;Cory Ann Leonard;Regenia Phillips Campbell;Barbara Prähauser;Theresa Pesch;Robert V. Schoborg;Ann E. Jerse;Bernadetta Tarigan;Nicole Borel
  • 通讯作者:
    Nicole Borel

Ann E. Jerse的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ann E. Jerse', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10362589
  • 财政年份:
    2019
  • 资助金额:
    $ 41.45万
  • 项目类别:
The Gonorrhea Vaccine Cooperative Research Center
淋病疫苗合作研究中心
  • 批准号:
    9900718
  • 财政年份:
    2019
  • 资助金额:
    $ 41.45万
  • 项目类别:
The Gonorrhea Vaccine Cooperative Research Center
淋病疫苗合作研究中心
  • 批准号:
    10362587
  • 财政年份:
    2019
  • 资助金额:
    $ 41.45万
  • 项目类别:
Neisserial OMV Vaccines
奈瑟氏菌 OMV 疫苗
  • 批准号:
    10362595
  • 财政年份:
    2019
  • 资助金额:
    $ 41.45万
  • 项目类别:
Neisserial OMV Vaccines
奈瑟氏菌 OMV 疫苗
  • 批准号:
    10588243
  • 财政年份:
    2019
  • 资助金额:
    $ 41.45万
  • 项目类别:
The Gonorrhea Vaccine Cooperative Research Center
淋病疫苗合作研究中心
  • 批准号:
    10588233
  • 财政年份:
    2019
  • 资助金额:
    $ 41.45万
  • 项目类别:
Continuing Preclinical Development of PPCM Vaginal Contraceptive MPT to IND
PPCM 阴道避孕药 MPT 至 IND 的持续临床前开发
  • 批准号:
    9889971
  • 财政年份:
    2017
  • 资助金额:
    $ 41.45万
  • 项目类别:
The Atlantic Coast Sexually Transmitted Infection Cooperative Research Center (AC
大西洋海岸性传播感染合作研究中心(AC
  • 批准号:
    9316484
  • 财政年份:
    2014
  • 资助金额:
    $ 41.45万
  • 项目类别:
The Atlantic Coast Sexually Transmitted Infection Cooperative Research Center (AC
大西洋海岸性传播感染合作研究中心(AC
  • 批准号:
    8769562
  • 财政年份:
    2014
  • 资助金额:
    $ 41.45万
  • 项目类别:
2014 International Pathogenic Neisseria Conference
2014年国际致病性奈瑟菌会议
  • 批准号:
    8785926
  • 财政年份:
    2014
  • 资助金额:
    $ 41.45万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 41.45万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.45万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 41.45万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.45万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 41.45万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 41.45万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.45万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 41.45万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 41.45万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.45万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了